Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 2, 2000, Pages 118-121

  Kazuhiko, Tsutsumi ^a   Yasuhide, Inoue ^a   Toshio, Murase ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

CAS 13320893 2; Lipoprotein lipase activator; NO 1886, effects on homozygous and heterozygous WHHL rabbits; 4 (4 Bromo 2 cyano phenylcarbamoyl) benzyl phosphonic acid diethyl ester

Indexed keywords

4 [(4 BROMO 2 CYANOPHENYL)CARBAMOYL]BENZYLPHOSPHONIC ACID DIETHYL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034090854     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300175     Document Type: Article

References (11)

1. [1] Tsutsumi, K., Inoue, Y., Shima, A. et al., The Novel Compound NO-1886 Increase Lipoprotein Lipase Activity with Resulting Elevation of High Density Lipoprotein Cholesterol, and Long-term Administration Inhibits Atherogenesis in the Coronary Arteries of Rats with Experimental Atherosclerosis. J. Clin. Invest. 91, 411 (1993)
2. [2] Tsutsumi, K., Inoue, Y., Shima, A. et al., Correction of hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol by the Novel Compound NO-1886, a Lipoprolein Lipase-Promoting Agent, in STZ-induced Diabetic Rats. Diabetes 44, 414 (1995)
3. [3] Tsutsumi, K., Inoue, Y., Hagi, A. et al., The Novel Compound NO-1886 Elevates Plasma High-Density Lipoprotein Cholesterol Levels in Hamsters and Rabbits by Increasing Lipoprotein Lipase Without Any Effect on Cholesterol Ester Transfer Protein Activity. Metabolism 46, 257 (1997)
4. [4] Chiba, T., Miura, S., Sawamura, F. et al., Antiatherogenic Effects of Novel Lipoprotein Lipase-Enhancing Agent in Cholesterol-Fed New Zealand White Rabbits. Arterioscler. Thromb. Vasc Biol. 17, 2601 (1997)
5. [5] Watanabe, Y., Serial Inbreeding of Rabbits with Hereditary Hyperlipidemia (WHHL-Rabbit). Atherosclerosis 36, 261 (1980)
6. [6] Kita, T., Brown, M. S., Watanabe, Y. et al., Deficiency of Low Density Lipoprotein Receptors in Liver and Adrenal Gland of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia. Proc. Natl. Acad. Sci. USA 78, 2268 (1981)
7. [7] Murase, T., Uchimura, H., A Selective Decline of Post-Heparin Plasma Hepatic Triglyceride Lipase in Hypothyroid Rats. Metab. Clin. Exp. 29, 797 (1980)
8. [8] Krauss, R. M., Windmueller, H. G., Levy, R. I. et al., Selective Measurement of Two Different Triglyceride Lipase Activities in Rat Postheparin Plasma. J. Lipid Res. 14, 286 (1973)
9. [9] Atkinson, J. B., Hoover, R. L., Berry, K. K. et al., Cholesterol-Fed Heterozygous Watanabe Heritable Hyperlipidemic Rabbits. Atherosclerosis 78, 123 (1989)
10. [10] Stein, O., Leitersdorf, E., Stein, Y., Verapamil Enhances Receptor-Mediated Endocytosis of Low Density Lipoproteins by Aorta Cells in Culture. Arteriosclerosis 5, 35 (1985)
11. [11] Ishikawa, Y., Watanabe, N., Okamoto, R. et al., Nifedipine Suppressed Atherosclerosis in Cholesterol-Fed Rabbits but in Watanabe Heritable Hyperlipidemic Rabbits. Atherosclerosis 64, 79 (1987)